Capsular Contracture, Explained: Why Scar Tissue Tightens Around Implants and What Actually Lowers the Risk

Every breast implant, regardless of brand, fill, or shell, triggers the same biological event: the body walls it off. Within weeks of surgery, fibroblasts deposit collagen around the device, forming a thin fibrous envelope called a capsule. This is normal. It is the same response the body mounts to a pacemaker or an orthopedic screw. A capsule only becomes a problem when it thickens and contracts, compressing the implant into a firmer, rounder, sometimes painful shape. That process is capsular contracture, and it remains the most common reason for reoperation after cosmetic breast augmentation.

How a normal capsule turns hostile

The leading explanation is the subclinical infection hypothesis. Bacteria, most often Staphylococcus epidermidis and Cutibacterium acnes from the patient's own skin and breast ducts, can adhere to the implant surface during placement. They do not cause a visible infection. Instead they form a biofilm, a slimy protective matrix that shields them from antibiotics and immune cells. The immune system responds with chronic low-grade inflammation, which drives fibroblasts to keep laying down collagen and, critically, to differentiate into myofibroblasts. Myofibroblasts contain contractile proteins similar to smooth muscle. When enough of them populate the capsule, they physically pull it tighter, like a drawstring closing around the implant.

Biofilm is not the only pathway. Hematoma, seroma, silicone gel bleed through the shell, and radiation therapy all feed the same inflammatory cascade. This is why contracture rates are meaningfully higher in reconstruction patients who receive radiation, sometimes exceeding 30 percent, versus low single digits in well-managed primary cosmetic cases.

The Baker grading system

Surgeons classify contracture on a four-point clinical scale. Grade I is a soft, natural-feeling breast, which is the goal. Grade II means the breast is slightly firm but looks normal. Grade III means the breast is firm and visibly distorted, often riding higher on the chest with an unnaturally round upper pole. Grade IV adds pain and significant hardness. Grades III and IV are generally the threshold for surgical revision. It is worth knowing that Baker grading is a physical exam finding, not an imaging diagnosis, and mild firmness alone does not mandate surgery.

What actually reduces the risk

Several practices have accumulated real evidence, mostly aimed at keeping bacteria off the implant.

Submuscular or dual-plane placement, meaning the implant sits partly or fully under the pectoralis major, is consistently associated with lower contracture rates than placement directly under the gland. Proposed mechanisms include greater distance from bacteria-rich breast duct tissue and constant muscle motion that may discourage biofilm organization.

The inframammary fold incision carries lower contracture rates than the periareolar incision in multiple large series. The likely reason is anatomical: a periareolar approach cuts through ducts that harbor bacteria, exposing the implant to contamination as it passes through.

Insertion funnels allow a no-touch technique in which the implant slides from sterile packaging into the pocket without contacting skin or gloves. Antibiotic or antiseptic pocket irrigation before insertion, fresh gloves for implant handling, nipple shields to occlude duct openings, and minimizing implant time in open air are all components of what surgeons call the 14-point plan. Individually each step is small. Collectively, series using these protocols report contracture rates well below historical norms.

Meticulous hemostasis matters because blood in the pocket is inflammatory fuel. Drains are used selectively for the same reason.

What does not hold up

Routine breast massage after augmentation is often prescribed, but controlled evidence that it prevents contracture is thin, and some surgeons argue it is irrelevant once the pocket has healed. Leukotriene inhibitors such as montelukast have shown mixed results in small studies for softening early contracture, and they carry their own risk profile, so they remain off-label and unproven rather than standard care. Ultrasound therapy and vitamin E have essentially no rigorous support.

Textured implants were once promoted as protective against contracture in subglandular placement, and some data supported that. However, macrotextured surfaces were later linked to breast implant associated anaplastic large cell lymphoma, which reshaped the risk calculation and shifted most markets heavily toward smooth devices. Contracture prevention today leans on technique, not texture.

If contracture happens anyway

Established Grade III to IV contracture is a surgical problem. Simply squeezing the capsule to rupture it, a closed capsulotomy, is obsolete and can damage the implant. Modern options include open capsulotomy, scoring the capsule to release it, or capsulectomy, removing part or all of the capsule, usually combined with a new implant and often a new pocket plane. Recurrence after revision is real, historically 10 to 25 percent, which is exactly why prevention protocols at the first operation matter so much.

The practical takeaway for patients: ask a prospective surgeon how they minimize contracture risk. A specific answer referencing pocket plane, incision choice, irrigation, and no-touch insertion signals someone engaged with the actual mechanism. A vague answer about massage does not.

Related reading: How long breast implants last and when to replace them.